| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $132.4B | $143.2B | $147.4B | $170.0B | $111.5B | $16.4B | $29.1B | $29.1B |
| Cost of Revenue | $116.1B | $130.0B | $128.1B | $149.9B | $102.1B | $57.7B | $95.5B | $97.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| SG&A Expense | $2.4B | $2.8B | $2.5B | $2.2B | $1.7B | $1.5B | $1.7B | $1.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $4.4B | $2.1B | $7.0B | $11.0B | $1.3B | $-0.5B | $0.7B | $2.2B |
| EPS (Basic) | $10.82 | $5.01 | $15.56 | $23.36 | $2.97 | $-1.23 | $1.65 | $4.85 |
| EPS (Diluted) | $10.79 | $4.99 | $15.48 | $23.27 | $2.97 | $-1.23 | $1.64 | $4.82 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $73.7B | $72.6B | $75.5B | $76.4B | $55.6B | $54.7B | $58.7B | $54.3B |
| Current Assets | $17.3B | $17.9B | $19.9B | $21.9B | $14.7B | $13.3B | $14.4B | $13.2B |
| Cash & Equivalents | $1.1B | $1.7B | $3.3B | $6.1B | $3.1B | $2.5B | $1.6B | $3.0B |
| Total Liabilities | $43.4B | $44.1B | $43.9B | $42.3B | $34.0B | $33.2B | $31.6B | $27.1B |
| Current Liabilities | $13.3B | $15.1B | $15.9B | $15.9B | $12.8B | $9.5B | $11.6B | $8.9B |
| Stockholders' Equity | $29.1B | $27.4B | $30.6B | $29.5B | $19.2B | $19.0B | $24.9B | $24.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.0B | $4.2B | $7.0B | $10.8B | $6.0B | $2.1B | $4.8B | $7.6B |
| Investing Cash Flow | $-2.1B | $-2.5B | $-1.8B | $-1.5B | $-1.9B | $-3.1B | $-3.7B | $-2.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-3.5B | $-3.3B | $-8.1B | $-6.4B | $-3.5B | $1.8B | $-2.5B | $-5.2B |